Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Simmonds

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
JRSM Open|May 12, 2017
<i>Burkholderia cepacia</i> complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case seriesMuttardi Kayria, Orchard Chris, Devesh J Dhasmana, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 22, 2008
An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 yearsMargaret E Hodson, Nicholas J Simmonds, Warren J Warwick, et al.
Plos Pathogens|February 4, 2025
Increased NFAT and NFκB signalling contribute to the hyperinflammatory phenotype in response to Aspergillus fumigatus in a mouse model of cystic fibrosisAmelia Bercusson, Thomas J Williams, Nicholas J Simmonds, et al.
Chest|July 22, 2022
Treatment Preference Among People With Cystic Fibrosis: The Importance of Reducing Treatment BurdenRory A Cameron, Daniel Office, Jessie Matthews, et al.
BMC Pulmonary Medicine|October 31, 2020
New strategies of physical activity assessment in cystic fibrosis: a pilot studyDaniela Savi, Luigi Graziano, Barbara Giordani, et al.
Pediatric Pulmonology|October 11, 2023
The effectiveness of CFTR modulators in people with CF and rare mutations: A real-world studySofia Hanger, Imogen Felton, Emem-Fong Ukor, et al.
Respiratory Medicine and Research|September 8, 2024
Evaluating the correspondence between the EQ-5D-5L and disease severity and quality of life in adults and adolescents with cystic fibrosisRana Altabee, Siobhan B Carr, Janice Abbott, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 15, 2024
Inhaled antimicrobial prescribing for Pseudomonas aeruginosa infections in EuropeCallum M Sloan, Laura J Sherrard, Gisli G Einarsson, et al.
American Journal of Respiratory and Critical Care Medicine|February 5, 2020
Whole-Gene Sequencing of <i>CFTR</i> Reveals a High Prevalence of the Intronic Variant c.3874-4522A>G in Cystic FibrosisDeborah J Morris-Rosendahl, Matthew Edwards, Melissa J McDonnell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 25, 2022
VOCAL: An observational study of ivacaftor for people with cystic fibrosis and selected non-G551D-CFTR gating mutationsNicholas J Simmonds, C Kors van der Ent, Carla Colombo, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
JRSM Open|May 12, 2017
<i>Burkholderia cepacia</i> complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case seriesMuttardi Kayria, Orchard Chris, Devesh J Dhasmana, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 22, 2008
An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 yearsMargaret E Hodson, Nicholas J Simmonds, Warren J Warwick, et al.
Plos Pathogens|February 4, 2025
Increased NFAT and NFκB signalling contribute to the hyperinflammatory phenotype in response to Aspergillus fumigatus in a mouse model of cystic fibrosisAmelia Bercusson, Thomas J Williams, Nicholas J Simmonds, et al.
Chest|July 22, 2022
Treatment Preference Among People With Cystic Fibrosis: The Importance of Reducing Treatment BurdenRory A Cameron, Daniel Office, Jessie Matthews, et al.
BMC Pulmonary Medicine|October 31, 2020
New strategies of physical activity assessment in cystic fibrosis: a pilot studyDaniela Savi, Luigi Graziano, Barbara Giordani, et al.
Pediatric Pulmonology|October 11, 2023
The effectiveness of CFTR modulators in people with CF and rare mutations: A real-world studySofia Hanger, Imogen Felton, Emem-Fong Ukor, et al.
Respiratory Medicine and Research|September 8, 2024
Evaluating the correspondence between the EQ-5D-5L and disease severity and quality of life in adults and adolescents with cystic fibrosisRana Altabee, Siobhan B Carr, Janice Abbott, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 15, 2024
Inhaled antimicrobial prescribing for Pseudomonas aeruginosa infections in EuropeCallum M Sloan, Laura J Sherrard, Gisli G Einarsson, et al.
American Journal of Respiratory and Critical Care Medicine|February 5, 2020
Whole-Gene Sequencing of <i>CFTR</i> Reveals a High Prevalence of the Intronic Variant c.3874-4522A>G in Cystic FibrosisDeborah J Morris-Rosendahl, Matthew Edwards, Melissa J McDonnell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 25, 2022
VOCAL: An observational study of ivacaftor for people with cystic fibrosis and selected non-G551D-CFTR gating mutationsNicholas J Simmonds, C Kors van der Ent, Carla Colombo, et al.
Pageof 7